Caution at psychiatry's psychedelic frontier
- PMID: 34635858
- DOI: 10.1038/s41591-021-01524-1
Caution at psychiatry's psychedelic frontier
Comment in
-
Reply to: Caution at psychiatry's psychedelic frontier and Challenges with benchmarking of MDMA-assisted psychotherapy.Nat Med. 2021 Oct;27(10):1691-1692. doi: 10.1038/s41591-021-01526-z. Epub 2021 Oct 11. Nat Med. 2021. PMID: 34635856 No abstract available.
Comment on
-
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study.Nat Med. 2021 Jun;27(6):1025-1033. doi: 10.1038/s41591-021-01336-3. Epub 2021 May 10. Nat Med. 2021. PMID: 33972795 Free PMC article. Clinical Trial.
References
-
- Mitchell, J. M. et al. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nat. Med. https://doi.org/10.1038/s41591-021-01336-3 (2021).
-
- Colloca, L. & Barsky, A. J. Placebo and nocebo effects. N. Engl. J. Med. 382, 554–561 (2020). 6. - DOI
-
- Ashar, Y. K., Chang, L. J. & Wager, T. D. Brain mechanisms of the placebo effect: an affective appraisal account. Annu Rev. Clin. Psychol. 13, 73–98 (2017). - DOI
-
- Burke, M. J., Kaptchuk, T. J. & Pascual-Leone, A. Challenges of differential placebo effects in contemporary medicine: the example of brain stimulation. Ann. Neurol. 85, 12–20 (2019). - DOI
-
- Feder, A. et al. Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry 71, 681–688 (2014). - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
